Ph1 Study of TNBC residual disease detection and therapy monitoring in patients with Breast Cancer
Phase I Clinical Trial
Breast Cancer-Minimal/Molecular Residual Disease Detection and Therapy Monitoring in Patients with Early Stage TNBC-Phase I (B-STRONGER-I) (01-PS-001)